ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Philadelphia, PA, USA:

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
Viewray

Philadelphia, Pennsylvania, United States and 12 other locations

control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...

Enrolling
Pancreatic Cancer
Device: Directional Brachytherapy Source Implant

Phase 1, Phase 2

CivaTech Oncology

Philadelphia, Pennsylvania, United States of America and 4 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Other: Placebo

Phase 2

Walid Shaib, MD

Philadelphia, Pennsylvania, United States and 7 other locations

Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...

Active, not recruiting
Pancreatic Neoplasm
Drug: Antroquinonol

Phase 1, Phase 2

Golden Biotechnology

Philadelphia, Pennsylvania, United States and 8 other locations

in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...

Enrolling
Metastatic Cancer
Neoplasms Pancreatic
Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

Phase 1, Phase 2

Verastem

Philadelphia, Pennsylvania, United States and 11 other locations

and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Enrolling
Advanced Pancreatic Cancer
Drug: Gemcitabine
Drug: Zimberelimab

Phase 1

Arcus Biosciences
Arcus Biosciences

Philadelphia, Pennsylvania, United States and 17 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Newark, Delaware, United States and 35 other locations

evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...

Enrolling
Siewert Type 1 GEJ Cancer
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
Drug: Oxaliplatin
Drug: Futibatinib

Phase 2

Taiho Pharma
Taiho Pharma

Mickleton, New Jersey, United States and 21 other locations

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: RenovoCath
Drug: nab-paclitaxel

Phase 3

RenovoRx

Camden, New Jersey, United States and 38 other locations

This is a Phase I study evaluating the safety and feasibility of lentiviral transduced huCART-meso cells when given in combination with VCN-01 in a 3...

Enrolling
Serous Ovarian Cancer
Pancreatic Cancer
Biological: huCART-meso Cells
Biological: VCN-01

Phase 1

University of Pennsylvania
University of Pennsylvania

Philadelphia, Pennsylvania, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems